Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Altwein

Showing results (41-50 of 177) with videos related to

Pageof 18
Sort By:
Der Urologe. Ausg. A|September 26, 2006
[Local recurrence of prostate cancer: hormone therapy]J E Altwein, T Ebert
Fortschritte Der Medizin|September 30, 1991
[Conservative therapy of prostate cancer]A Leitenberger, J E Altwein
European Urology|January 1, 1990
Efficacy and discriminative ability of prostate-specific antigen as a tumor markerA Leitenberger, J E Altwein
Der Urologe. Ausg. A|January 1, 1987
[Advanced prostate cancer--a therapeutic dilemma?]H Rübben, J E Altwein
Der Urologe. Ausg. A|January 1, 1991
[Chemotherapy of prostatic carcinoma]M Wirth, J E Altwein
Urologia Internationalis|December 11, 1999
Prognostic factors for carcinoma of the prostateJ E Altwein, H J Luboldt
MMW Fortschritte Der Medizin|February 19, 2002
[Early detection and follow-up of prostatic carcinoma. Responsibilities of the general practitioner]F U Keuler, J E Altwein
Urologia Internationalis|February 24, 2006
Biphosphonates in advanced prostate and renal cell cancer--current status and potential applicationsC E Hoesl, J E Altwein
Der Urologe. Ausg. A|November 1, 1980
[Hormone therapy of prostatic cancer (author's transl)]J E Altwein, G H Jacobi
Der Urologe. Ausg. A|September 1, 1978
[Double malformations of the upper urinary tract: complications in adults (author's transl)]P H Walz, J E Altwein
Pageof 18

Showing results (41-50 of 177) with videos related to

Sort By:
Pageof 18
Der Urologe. Ausg. A|September 26, 2006
[Local recurrence of prostate cancer: hormone therapy]J E Altwein, T Ebert
Fortschritte Der Medizin|September 30, 1991
[Conservative therapy of prostate cancer]A Leitenberger, J E Altwein
European Urology|January 1, 1990
Efficacy and discriminative ability of prostate-specific antigen as a tumor markerA Leitenberger, J E Altwein
Der Urologe. Ausg. A|January 1, 1987
[Advanced prostate cancer--a therapeutic dilemma?]H Rübben, J E Altwein
Der Urologe. Ausg. A|January 1, 1991
[Chemotherapy of prostatic carcinoma]M Wirth, J E Altwein
Urologia Internationalis|December 11, 1999
Prognostic factors for carcinoma of the prostateJ E Altwein, H J Luboldt
MMW Fortschritte Der Medizin|February 19, 2002
[Early detection and follow-up of prostatic carcinoma. Responsibilities of the general practitioner]F U Keuler, J E Altwein
Urologia Internationalis|February 24, 2006
Biphosphonates in advanced prostate and renal cell cancer--current status and potential applicationsC E Hoesl, J E Altwein
Der Urologe. Ausg. A|November 1, 1980
[Hormone therapy of prostatic cancer (author's transl)]J E Altwein, G H Jacobi
Der Urologe. Ausg. A|September 1, 1978
[Double malformations of the upper urinary tract: complications in adults (author's transl)]P H Walz, J E Altwein
Pageof 18